Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Lab7 Systems Launches BioBuilds, SeqSigma, and DashO3 to Accelerate and Streamline Genomic Data Processing

Published: Wednesday, September 04, 2013
Last Updated: Wednesday, September 04, 2013
Bookmark and Share
Free software and new services reduce dependencies and improve genomic workflow processes.

Lab7 Systems, Inc., announced that it has released a free software toolkit and new service offerings for the next-generation DNA sequencing (NGS) bioinformatics community, along with the latest beta version of its Lab7 Dashboard.  BioBuildsTM is a reference collection of Open Source bioinformatics tools for genomics, pre-built for Linux and Mac OS X platforms.  It eliminates the need for users to maintain and build their own versions of these tools.  By providing binaries, BioBuilds also enables users to easily reproduce results by removing version dependencies on underlying software, since all tools in BioBuilds will be pre-built for those binaries.

"Open Source software is important for bioinformatics", said Chris Mueller, Ph.D., Lab7 Systems’ President and Chief Technology Officer.  "However, building and maintaining Open Source tools can be a time consuming process.  We maintain internal builds of many analytical tools and we feel that making our builds freely available is a good way to give back to the genomics community."

BioBuilds is being released in conjunction with the second Public Beta of the Lab7 Dashboard, the company’s comprehensive software platform for managing sequencing projects, workflows, and pipelines.  This release includes the Production Pipeline Engine, a complete sequence analysis pipeline management and report generation system.  The Production Pipeline Engine allows users to easily port existing analysis pipelines into a managed, production-ready environment.  All BioBuilds tools are made readily available in the Lab7 Dashboard, even though the platform is not expressly required to run the tools.

Lab7 Systems also launched its SeqSigmaTM and DashO3TM optimization processes, integral components of the company’s larger suite of custom services.  The SeqSigma process utilizes clients’ sequencing and analysis goals to design and implement cost-effective computational infrastructures that scale with their labs, while the DashO3 pipeline optimization process identifies computational and dataflow bottlenecks in sequence analysis pipelines and can increase performance by two- to tenfold.

“Everything we’re launching today supports our vision of a streamlined environment for the management and analysis of NGS data,” concluded Dr. Mueller.  “With the tools we’re providing, we know that we can reduce the burden on bioinformaticians, scientists, and clinicians, allowing them to refocus their efforts to accelerate scientific discovery and clinical diagnoses.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Probing How CRISPR-Cas9 Works
New study in Journal of Cell Biology examines DNA targeting dynamics in live cells.
Diagnosing Tumors of Unknown Origin
EPICUP® test is a tool that helps to identify up to 87% of cancers of unknown origin (COD).
Genome Editing Without Cleaving DNA
A team involving Kobe University researchers has succeeded in developing ‘Target-AID’, a genome editing technique that does not cleave the DNA.
New Possibilities Tumor Research
Grazer researchers say gene activity of the tumor from the analysis of circulating DNA in blood ahead.
Controlling Genome Editing with Light
New technique offers precise manipulation of when and where genes are targeted.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Lose Weight, Escape the Eight: Weight-Based Cancer Risk
IARC has identified eight additional cancer sites linked to overweight and obesity.
Coffee Consumption Linked to Genes
Researchers have identified a gene that influences coffee consumption. The gene is thought to relate to caffeine breakdown.
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!